Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.
about
Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysisExercise-based rehabilitation for heart failureReporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic reviewEffect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic ReviewClinical adoption of prognostic biomarkers: the case for heart failureHeart failure with preserved ejection fraction.Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.Diastolic chamber properties of the left ventricle assessed by global fitting of pressure-volume data: improving the gold standard of diastolic functionDiastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes.Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principlesEffects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.Bucindolol: a pharmacogenomic perspective on its use in chronic heart failureTestosterone suppresses ventricular remodeling and improves left ventricular function in rats following myocardial infarction.Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry.The role of a structured exercise training program on cardiac structure and function after acute myocardial infarction: study protocol for a randomized controlled trialTowards 'Eternal Youth' of cardiac and skeletal muscle.The Effect of Exercise Training on Diastolic and Systolic Function After Acute Myocardial Infarction: A Randomized Study.Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fractionExercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials.Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilTherapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Heart failure treatment in the elderly.Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.Developments in heart failure 2011.Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.Physical therapy in heart failure with preserved ejection fraction: A systematic review.Clinical outcomes and cardiovascular responses to exercise training in heart failure patients with preserved ejection fraction: a systematic review and meta-analysis.Aging Effects on Cardiac Progenitor Cell Physiology.Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.The clinical dilemma of heart failure with preserved ejection fraction: an update on pathophysiology and management for physicians.Response to Endurance Exercise Training in Older Adults with Heart Failure with Preserved or Reduced Ejection Fraction.Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).Novel Endpoints for Heart Failure Clinical Trials.The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
P2860
Q21132299-86D8D94F-86F3-4442-8285-EC24690D9E68Q24194994-4AD255A7-E675-465E-A5F2-2A06804494F0Q26779538-5094C59D-13DF-49D4-8747-3D63245BC024Q26783958-DE580BE9-1928-4B51-869C-7ACE1E6A3863Q26863716-0D106721-CFD4-42D2-AD98-E4297A908BA4Q30420528-54BEF1E9-900E-4D9E-AFE3-10C00F42860CQ30435143-E14BB9C6-E154-47ED-8CE0-92625F322B0DQ30642275-4E432B90-4D94-4463-8B35-4065F2919C41Q34984569-853B3BCD-4EAB-4013-97D9-F4A8AD564379Q34999474-02747BCB-3161-4262-A74E-D6797D02364FQ35018046-55122A05-4748-4334-99D4-908E5DBF72FFQ35117742-A2426C61-363E-4F0A-9B80-F7297E01515BQ35159728-111187FD-E6F4-4ED6-80ED-B0B82890C2C3Q35170235-97E7D6DE-A2B9-4C32-BE09-2C82A6EAA404Q35177237-7A032003-C40B-4085-9399-3D91D1A910DFQ35662642-998ADF89-7C2C-4BA7-AEED-D90D7795D3D4Q36194983-76B99BAB-1232-4826-ADA0-84EC83405476Q36524840-1559EE90-DDBC-48E3-96A8-2ABE460789F6Q36687730-BF1FAB0B-2508-4207-8B40-291F2DFAC5ACQ37058596-D82A5071-5416-488B-BFAC-4CC871A4B815Q37292234-B6217E1D-5D1C-4FC4-85F3-80ECF496CBF8Q37390329-A25542FB-3854-4EE9-A4E4-176CCE4EBC96Q37603728-67C90B5D-CF32-4BBF-B4F7-D01F5033BEE1Q37633991-CDA06CDC-A5E5-44CF-85F9-95000365AED1Q37935778-26203988-CAFC-4B59-B845-3093D1E3ACB9Q37993133-D0BAD8FE-6B59-4CD7-B838-FAB3213284BDQ37995246-5C8E5CD2-A7D4-4956-9CDA-4A275F56F55AQ38042554-AA65DBBC-503C-4C36-B41A-786625D2BFEAQ38285563-57E5268B-E680-4B5E-9801-D6AFC0C239E7Q38370048-FF8D3135-6D30-4048-98A4-C9455B6098ACQ38596695-0F7ADF25-3A00-4116-814C-856F0D1EAFCDQ38638655-51E5925C-5ACD-468F-8396-7FD4EA5C9418Q38768799-3454EC4A-8522-44D4-A375-2F8C47CD1184Q38880142-9AE6F6E1-06DE-41F4-888C-BAA0BDCFD476Q38932720-5CE6D4D3-F274-43F8-ACAC-C3C4865A03CFQ38978490-BAB34474-3A48-45D4-9FD0-BCF84819C65CQ39268911-8E59927B-A250-45C8-ACDF-FD0089E9BD06Q39396838-32F15C34-0228-43B8-BE8D-C25BE838A193Q39456492-9D84B290-7935-430F-8331-2125EE8AB251Q43745028-A7BF3C57-F58F-405B-81C2-91C7A759FC5C
P2860
Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@en
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@nl
type
label
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@en
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@nl
prefLabel
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@en
Effects of treatment on exerci ...... ion fraction. A meta-analysis.
@nl
P2093
P1476
Effects of treatment on exerci ...... tion fraction. A meta-analysis
@en
P2093
Dharam J Kumbhani
Salim H Ahmed
Thomas H Marwick
P304
P356
10.1016/J.JACC.2010.10.057
P407
P577
2011-04-01T00:00:00Z